Significant advances in automated microscopy, imaging, and biological models are delivering more predictive, physiologically-relevant measurements for drug discovery and environmental toxicity applications. Yet, implementation challenges have been a deterrent for utilizing 3D spheroid models.
This webinar will explore the use and analysis of cancer spheroid models, as well as iPSC-derived hepatocyte and cardiomyocyte spheroids for toxicity assessment and demonstrate that historical barriers have been overcome.
Join us to learn about:
- Selecting products and solutions for implementation of 3D spheroid models
- Testing efficacy of anticancer drugs using cancer spheroids
- Analyzing phenotypic characterization of compound treatments on iPSC-derived hepatocyte spheroids
- Assessing drug effects on cardiomyocyte physiology using human iPSC-derived cardiac spheroids